DMD Bio-Rad Microplate Reader

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0090-9556/04/3201-66-71$20.00
DMD 32:66-71, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shenoy, S. D.
Right arrow Articles by Kocarek, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shenoy, S. D.
Right arrow Articles by Kocarek, T. A.

CYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTOR

Sarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris, and Thomas A. Kocarek

Institute of Environmental Health Sciences, Wayne State University, Detroit, Michigan (S.D.S., N.A.M.-H., M.A., M.D.G., M.R.M., T.A.K.) and Department of Chemistry, Dartmouth College, Hanover, New Hampshire (T.A.S.)

The effects of oxysterol and drug ligands of the liver X receptor (LXR) on cytochrome P450 expression were evaluated in primary cultured rodent hepatocytes. Treatment of rat hepatocyte cultures with either 25-hydroxycholesterol or 24(S),25-epoxycholesterol (10–5 to 5 x 10–5 M) produced concentration-dependent elevations in CYP3A mRNA and immunoreactive protein levels but did not increase the amounts of CYP1A1, CYP2B, or CYP4A gene products. The effects of 24(S),25-epoxycholesterol on CYP3A content were much greater than were those of 25-hydroxycholesterol, consistent with the relative abilities of these sterols to bind and activate LXR. To understand the mechanistic basis of these observations, experiments were performed using primary cultured hepatocytes prepared from LXR{alpha}/ß- or pregnane X receptor (PXR)-null mice. CYP3A mRNA levels were increased after treatment with 24(S),25-epoxycholesterol in both wild-type and LXR-null mouse hepatocytes. In contrast, neither 24(S),25-epoxycholesterol nor either of two additional potent LXR ligands, 22(R)-hydroxycholesterol and N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1(trifluoromethyl)ethyl-]phenyl]-benzenesulfonamide (T0901317), altered CYP3A mRNA levels in hepatocytes prepared from PXR-null mice, although these agents induced CYP3A mRNA content in wild-type cultures. As evidence that the LXR ligands also activated PXR in rat hepatocytes, cotransfection of primary cultures with a dominant negative PXR abolished reporter gene induction after treatment with any of the test agents. These results indicate that selected LXR ligands are capable of activating PXR, probably as a defensive measure to prevent the accumulation of these potentially toxic endogenous molecules.


Address correspondence to: Dr. Thomas A. Kocarek, Institute of Environmental Health Sciences, 2727 Second Avenue, Room 4000, Detroit, MI 48201. E-mail: t.kocarek{at}wayne.edu




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
H. Gong, P. Guo, Y. Zhai, J. Zhou, H. Uppal, M. J. Jarzynka, W.-C. Song, S.-Y. Cheng, and W. Xie
Estrogen Deprivation and Inhibition of Breast Cancer Growth in Vivo through Activation of the Orphan Nuclear Receptor Liver X Receptor
Mol. Endocrinol., August 1, 2007; 21(8): 1781 - 1790.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. J. Delvecchio, P. Bilan, K. Radford, J. Stephen, B. L. Trigatti, G. Cox, K. Parameswaran, and J. P. Capone
Liver X Receptor Stimulates Cholesterol Efflux and Inhibits Expression of Proinflammatory Mediators in Human Airway Smooth Muscle Cells
Mol. Endocrinol., June 1, 2007; 21(6): 1324 - 1334.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
T. Li, W. Chen, and J. Y. L. Chiang
PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine
J. Lipid Res., February 1, 2007; 48(2): 373 - 384.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. J. Langmade, S. E. Gale, A. Frolov, I. Mohri, K. Suzuki, S. H. Mellon, S. U. Walkley, D. F. Covey, J. E. Schaffer, and D. S. Ory
Pregnane X receptor (PXR) activation: A mechanism for neuroprotection in a mouse model of Niemann-Pick C disease
PNAS, September 12, 2006; 103(37): 13807 - 13812.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Chu, M. Miyazaki, W. C. Man, and J. M. Ntambi
Stearoyl-Coenzyme A Desaturase 1 Deficiency Protects against Hypertriglyceridemia and Increases Plasma High-Density Lipoprotein Cholesterol Induced by Liver X Receptor Activation.
Mol. Cell. Biol., September 1, 2006; 26(18): 6786 - 6798.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Weinhofer, M. Kunze, H. Rampler, A. L. Bookout, S. Forss-Petter, and J. Berger
Liver X Receptor {alpha} Interferes with SREBP1c-mediated Abcd2 Expression: NOVEL CROSS-TALK IN GENE REGULATION
J. Biol. Chem., December 16, 2005; 280(50): 41243 - 41251.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Gnerre, G. U. Schuster, A. Roth, C. Handschin, L. Johansson, R. Looser, P. Parini, M. Podvinec, K. Robertsson, J.-A. Gustafsson, et al.
LXR deficiency and cholesterol feeding affect the expression and phenobarbital-mediated induction of cytochromes P450 in mouse liver
J. Lipid Res., August 1, 2005; 46(8): 1633 - 1642.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H.-L. Fang, S. C. Strom, H. Cai, C. N. Falany, T. A. Kocarek, and M. Runge-Morris
Regulation of Human Hepatic Hydroxysteroid Sulfotransferase Gene Expression by the Peroxisome Proliferator-Activated Receptor {alpha} Transcription Factor
Mol. Pharmacol., April 1, 2005; 67(4): 1257 - 1267.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. A. Kliewer
Cholesterol detoxification by the nuclear pregnane X receptor
PNAS, February 22, 2005; 102(8): 2675 - 2676.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Sonoda, L. W. Chong, M. Downes, G. D. Barish, S. Coulter, C. Liddle, C.-H. Lee, and R. M. Evans
Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites
PNAS, February 8, 2005; 102(6): 2198 - 2203.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. Phillips, S. R. Hood, G. G. Gibson, and N. J. Plant
IMPACT OF TRANSCRIPTION FACTOR PROFILE AND CHROMATIN CONFORMATION ON HUMAN HEPATOCYTE CYP3A GENE EXPRESSION
Drug Metab. Dispos., February 1, 2005; 33(2): 233 - 242.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Kotokorpi, C. Gardmo, C. S. Nystrom, and A. Mode
Activation of the Glucocorticoid Receptor or Liver X Receptors Interferes with Growth Hormone-Induced akr1b7 Gene Expression in Rat Hepatocytes
Endocrinology, December 1, 2004; 145(12): 5704 - 5713.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. D. Shenoy, T. A. Spencer, N. A. Mercer-Haines, M. Abdolalipour, W. L. Wurster, M. Runge-Morris, and T. A. Kocarek
Induction of CYP3A by 2,3-Oxidosqualene:Lanosterol Cyclase Inhibitors Is Mediated by an Endogenous Squalene Metabolite in Primary Cultured Rat Hepatocytes
Mol. Pharmacol., May 1, 2004; 65(5): 1302 - 1312.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.